Skip to main content
Clinical Trials/CTRI/2022/03/041516
CTRI/2022/03/041516
Completed
未知

A multi-centric, cross-sectional, observational study of pregnancy test kit for rapid detection of pregnancy in subjects scheduled for detection of Pregnancy.

Mankind Pharma Limited Mankind Pharma Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mankind Pharma Limited Mankind Pharma Limited
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Pms

Investigators

Sponsor
Mankind Pharma Limited Mankind Pharma Limited

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy female subjects of child\-bearing age group of ââ?°Â¥18 to ââ?°Â¤50 years.
  • 2\. Who either request a pregnancy test, or require a pregnancy test for diagnostic studies or treatment.
  • 3\. Written informed consent from the subject, legally acceptable representative or parent and able to follow study procedures.

Exclusion Criteria

  • Subjects who are not able to or not willing to sign an IRB/IEC approved consent form.
  • 2\. Known pregnancy.
  • 3\. Symptomatic COVID\-19 suspected subjects (as assessed by the COVID\-19 Questionnaire).
  • 4\. Hemodynamically unstable.
  • 5\. Moderately to severely ill\-appearing or in moderate to severe pain.
  • 6\. Technically not possible to obtain blood from the study subject.

Outcomes

Primary Outcomes

Not specified

Similar Trials